α-Synuclein and Mitochondria: Probing the Dynamics of Disordered Membrane-protein Regions Using Solid-State Nuclear Magnetic Resonance
JACS Au,
Journal Year:
2024,
Volume and Issue:
4(6), P. 2372 - 2380
Published: May 28, 2024
The
characterization
of
intrinsically
disordered
regions
(IDRs)
in
membrane-associated
proteins
is
crucial
importance
to
elucidate
key
biochemical
processes,
including
cellular
signaling,
drug
targeting,
or
the
role
post-translational
modifications.
These
protein
pose
significant
challenges
powerful
analytical
techniques
molecular
structural
investigations.
We
here
applied
magic
angle
spinning
solid-state
nuclear
magnetic
resonance
quantitatively
probe
dynamics
IDRs
membrane-bound
α-synuclein
(αS),
a
whose
aggregation
associated
with
Parkinson's
disease
(PD).
focused
on
mitochondrial
binding
αS,
an
interaction
that
has
functional
and
pathological
relevance
neuronal
cells
considered
for
underlying
mechanisms
PD.
Transverse
longitudinal
15N
relaxation
revealed
dynamical
properties
αS
bound
outer
membrane
(OMM)
are
different
from
those
cytosolic
state,
thus
indicating
generally
not
interact
fact
affected
by
spatial
proximity
lipid
bilayer.
Moreover,
changes
composition
OMM
dyshomeostasis
PD
were
found
significantly
perturb
topology
state
αS.
Taken
together,
our
data
underline
characterizing
achieve
accurate
understanding
these
elusive
play
numerous
processes
occurring
surfaces.
Language: Английский
Amyloid-Driven Allostery
J. S. Garcha,
No information about this author
Jinfeng Huang,
No information about this author
Karla Martinez Pomier
No information about this author
et al.
Biophysical Chemistry,
Journal Year:
2024,
Volume and Issue:
315, P. 107320 - 107320
Published: Aug. 30, 2024
The
fields
of
allostery
and
amyloid-related
pathologies,
such
as
Parkinson's
disease
(PD),
have
been
extensively
explored
individually,
but
less
is
known
about
how
amyloids
control
allostery.
Recent
advancements
revealed
that
can
drive
allosteric
effects
in
both
intrinsically
disordered
proteins,
alpha-synuclein
(αS),
multi-domain
signaling
protein
kinase
A
(PKA).
Amyloid-driven
plays
a
central
role
explaining
the
mechanisms
gain-of-pathological-function
mutations
αS
(e.g.
E46K,
which
causes
early
PD
onset)
loss-of-physiological-function
PKA
A211D,
predisposes
to
tumors).
This
review
highlights
disease-related
they
cause
exposure
amyloidogenic
regions,
leading
are
either
toxic
or
aberrant
signaling.
We
also
discuss
multiple
potential
modulators
these
effects,
MgATP
substrates,
opening
future
opportunities
improve
current
pharmacological
interventions
against
PKA-related
pathologies.
Overall,
we
show
amyloid-driven
models
useful
explain
underlying
mutations.
Language: Английский